What is the dosing for tranexamic acid (TXA) in the treatment of menorrhagia (heavy menstrual bleeding)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 9, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Research

For heavy bleeding, the most effective dosing of tranexamic acid is 1 gram intravenously over 10 minutes, followed by another 1 gram if bleeding continues after 30 minutes or restarts within 24 hours, as supported by the most recent and highest quality study 1.

Key Considerations

  • The dosing of tranexamic acid may vary depending on the clinical context, such as trauma, postpartum hemorrhage, or surgical bleeding.
  • Early administration of tranexamic acid is crucial for efficacy, particularly in trauma and postpartum hemorrhage 1.
  • The medication works by inhibiting plasminogen activation, which prevents the breakdown of blood clots and helps control bleeding.
  • Side effects may include nausea, vomiting, diarrhea, and rarely, thromboembolic events.
  • Dose adjustments are necessary for patients with kidney impairment.

Clinical Contexts

  • For acute trauma or postpartum hemorrhage, the standard dose is 1 gram intravenously over 10 minutes, followed by another 1 gram if bleeding continues after 30 minutes or restarts within 24 hours.
  • For surgical bleeding, 10-15 mg/kg intravenously before surgery and potentially repeated during or after surgery may be used.
  • For heavy menstrual bleeding, tranexamic acid can be dosed at 1,000-1,300 mg orally three times daily for 3-5 days during menstruation, starting when bleeding begins.

Important Notes

  • Tranexamic acid is contraindicated in patients with active thromboembolic disease, subarachnoid hemorrhage, or hypersensitivity to tranexamic acid.
  • The use of tranexamic acid should be individualized, taking into account the patient's specific clinical context and risk factors for bleeding and thrombosis 1, 2.

References

Research

When to use tranexamic acid for the treatment of major bleeding?

Journal of thrombosis and haemostasis : JTH, 2024

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.